Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer.


Journal

JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827

Informations de publication

Date de publication:
06 2021
Historique:
received: 15 12 2020
revised: 12 01 2021
accepted: 27 01 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 28 5 2021
Statut: epublish

Résumé

Incidence of early-onset (younger than 50 years of age) colorectal cancer (CRC) is increasing in many countries. Thus, elucidating the role of traditional CRC risk factors in early-onset CRC is a high priority. We sought to determine whether risk factors associated with late-onset CRC were also linked to early-onset CRC and whether association patterns differed by anatomic subsite. Using data pooled from 13 population-based studies, we studied 3767 CRC cases and 4049 controls aged younger than 50 years and 23 437 CRC cases and 35 311 controls aged 50 years and older. Using multivariable and multinomial logistic regression, we estimated odds ratios (ORs) and 95% confidence intervals (CIs) to assess the association between risk factors and early-onset CRC and by anatomic subsite. Early-onset CRC was associated with not regularly using nonsteroidal anti-inflammatory drugs (OR = 1.43, 95% CI = 1.21 to 1.68), greater red meat intake (OR = 1.10, 95% CI = 1.04 to 1.16), lower educational attainment (OR = 1.10, 95% CI = 1.04 to 1.16), alcohol abstinence (OR = 1.23, 95% CI = 1.08 to 1.39), and heavier alcohol use (OR = 1.25, 95% CI = 1.04 to 1.50). No factors exhibited a greater excess in early-onset compared with late-onset CRC. Evaluating risks by anatomic subsite, we found that lower total fiber intake was linked more strongly to rectal (OR = 1.30, 95% CI = 1.14 to 1.48) than colon cancer (OR = 1.14, 95% CI = 1.02 to 1.27; In this large study, we identified several nongenetic risk factors associated with early-onset CRC, providing a basis for targeted identification of those most at risk, which is imperative in mitigating the rising burden of this disease.

Sections du résumé

Background
Incidence of early-onset (younger than 50 years of age) colorectal cancer (CRC) is increasing in many countries. Thus, elucidating the role of traditional CRC risk factors in early-onset CRC is a high priority. We sought to determine whether risk factors associated with late-onset CRC were also linked to early-onset CRC and whether association patterns differed by anatomic subsite.
Methods
Using data pooled from 13 population-based studies, we studied 3767 CRC cases and 4049 controls aged younger than 50 years and 23 437 CRC cases and 35 311 controls aged 50 years and older. Using multivariable and multinomial logistic regression, we estimated odds ratios (ORs) and 95% confidence intervals (CIs) to assess the association between risk factors and early-onset CRC and by anatomic subsite.
Results
Early-onset CRC was associated with not regularly using nonsteroidal anti-inflammatory drugs (OR = 1.43, 95% CI = 1.21 to 1.68), greater red meat intake (OR = 1.10, 95% CI = 1.04 to 1.16), lower educational attainment (OR = 1.10, 95% CI = 1.04 to 1.16), alcohol abstinence (OR = 1.23, 95% CI = 1.08 to 1.39), and heavier alcohol use (OR = 1.25, 95% CI = 1.04 to 1.50). No factors exhibited a greater excess in early-onset compared with late-onset CRC. Evaluating risks by anatomic subsite, we found that lower total fiber intake was linked more strongly to rectal (OR = 1.30, 95% CI = 1.14 to 1.48) than colon cancer (OR = 1.14, 95% CI = 1.02 to 1.27;
Conclusion
In this large study, we identified several nongenetic risk factors associated with early-onset CRC, providing a basis for targeted identification of those most at risk, which is imperative in mitigating the rising burden of this disease.

Identifiants

pubmed: 34041438
doi: 10.1093/jncics/pkab029
pii: pkab029
pmc: PMC8134523
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Dietary Fiber 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Subventions

Organisme : AHRQ HHS
ID : T32 HS026120
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA114347
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034987
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA066635
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244588
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA230162
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA122839
Pays : United States
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C588/A19167
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P50 CA127003
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA076366
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA215775
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206279
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA148107
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167551
Pays : United States
Organisme : NCI NIH HHS
ID : P20 CA252728
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA136726
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164930
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA081488
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074783
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA015704
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Références

Am J Public Health. 2016 Sep;106(9):1567-72
pubmed: 27459459
Int J Cancer. 2004 Jan 20;108(3):433-42
pubmed: 14648711
N Engl J Med. 2005 May 26;352(21):2184-92
pubmed: 15917383
Am Surg. 2018 Jul 1;84(7):1229-1235
pubmed: 30064594
Cancer Causes Control. 2013 Feb;24(2):335-41
pubmed: 23224326
Obesity (Silver Spring). 2008 May;16(5):1099-104
pubmed: 18356841
World J Gastroenterol. 2014 Sep 21;20(35):12420-30
pubmed: 25253942
Gastroenterology. 2020 Jul;159(1):241-256.e13
pubmed: 32247020
Gastroenterology. 2019 Mar;156(4):958-965
pubmed: 30521807
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1695-8
pubmed: 19505901
J Clin Gastroenterol. 2020 Sep;54(8):714-719
pubmed: 32520886
Gastroenterology. 2013 Apr;144(4):799-807.e24
pubmed: 23266556
Gut. 2019 Dec;68(12):2179-2185
pubmed: 31488504
Gastroenterology. 2020 Jan;158(2):341-353
pubmed: 31394082
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376186
World J Gastrointest Oncol. 2019 Nov 15;11(11):1011-1020
pubmed: 31798781
Int J Colorectal Dis. 2019 Jul;34(7):1221-1226
pubmed: 31102007
Clin Gastroenterol Hepatol. 2019 Jan;17(1):115-122
pubmed: 30025922
Int J Epidemiol. 1994 Oct;23(5):991-9
pubmed: 7860180
JNCI Cancer Spectr. 2018 Nov;2(4):pky073
pubmed: 30740587
World J Gastroenterol. 2016 Apr 7;22(13):3611-20
pubmed: 27053853
Am J Nurs. 1978 Jun;78(6):1039-40
pubmed: 248266
BMJ Open Gastroenterol. 2019 Aug 24;6(1):e000313
pubmed: 31523441
Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):83-90
pubmed: 30530848
Soc Sci Med. 2000 Sep;51(6):955-67
pubmed: 10972438
Nutrients. 2011 Mar;3(3):370-84
pubmed: 22254102
PLoS Genet. 2014 Apr 17;10(4):e1004228
pubmed: 24743840
Clin Colorectal Cancer. 2017 Dec;16(4):293-299.e6
pubmed: 29033218
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Prev Med. 2017 Dec;105:345-349
pubmed: 28987338
Gastroenterology. 2018 Dec;155(6):1716-1719.e4
pubmed: 30165046
J Gastroenterol Hepatol. 2015 Jan;30(1):6-13
pubmed: 25251195
BMJ Open Gastroenterol. 2019 Dec 02;6(1):e000339
pubmed: 31875139
Gastroenterology. 2018 Jun;154(8):2152-2164.e19
pubmed: 29458155
Gastroenterology. 2020 Aug;159(2):492-501.e7
pubmed: 31926997
Open Heart. 2017 Apr 28;4(1):e000550
pubmed: 28674622
Ann Intern Med. 2011 Jan 4;154(1):22-30
pubmed: 21200035
JAMA Surg. 2015 Jan;150(1):17-22
pubmed: 25372703
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Dig Dis Sci. 2019 Dec;64(12):3602-3609
pubmed: 31175493
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1323-1331.e6
pubmed: 30056182
Cancer. 2019 Jun 15;125(12):2002-2010
pubmed: 30854646
Gastroenterology. 2020 Apr;158(5):1274-1286.e12
pubmed: 31866242
JAMA Oncol. 2019 Jan 1;5(1):37-44
pubmed: 30326010
West J Med. 2000 Dec;173(6):378-83
pubmed: 11112748
Cancer Res. 1997 Jan 1;57(1):75-80
pubmed: 8988044
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43
pubmed: 17982118
Cancer Epidemiol. 2019 Apr;59:29-36
pubmed: 30660075
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2752-2759.e2
pubmed: 31622737
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107
pubmed: 16434594

Auteurs

Alexi N Archambault (AN)

Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA.

Yi Lin (Y)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Jihyoun Jeon (J)

Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.

Tabitha A Harrison (TA)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

D Timothy Bishop (DT)

Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Graham Casey (G)

Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.

Andrew T Chan (AT)

Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.

Jenny Chang-Claude (J)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany.

Jane C Figueiredo (JC)

Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Steven Gallinger (S)

Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Stephen B Gruber (SB)

Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA.

Marc J Gunter (MJ)

Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.

Michael Hoffmeister (M)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Mark A Jenkins (MA)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Temitope O Keku (TO)

Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.

Loïc Le Marchand (LL)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Li Li (L)

Department of Family Medicine, University of Virginia, Charlottesville, VA, USA.

Victor Moreno (V)

Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Polly A Newcomb (PA)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
School of Public Health, University of Washington, Seattle, WA, USA.

Rish Pai (R)

Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

Patrick S Parfrey (PS)

Memorial University, Faculty of Medicine, Newfoundland, Canada.

Gad Rennert (G)

Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.
Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Clalit National Cancer Control Center, Haifa, Israel.

Lori C Sakoda (LC)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

Robert S Sandler (RS)

Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.

Martha L Slattery (ML)

Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.

Mingyang Song (M)

Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.

Aung Ko Win (AK)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Michael O Woods (MO)

Memorial University of Newfoundland, Discipline of Genetics, St John's, Canada.

Neil Murphy (N)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

Peter T Campbell (PT)

Department of Population Science, American Cancer Society, Atlanta, GA, USA.

Yu-Ru Su (YR)

Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.

Anne Zeleniuch-Jacquotte (A)

Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA.

Peter S Liang (PS)

Department of Medicine, New York University School of Medicine, New York, NY, USA.

Mengmeng Du (M)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Li Hsu (L)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Biostatistics, University of Washington, Seattle, WA, USA.

Ulrike Peters (U)

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.

Richard B Hayes (RB)

Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH